David Eidelberg

Last updated

David Eidelberg
Nationality American
Education Columbia University, Harvard Medical School
Occupation(s) Physician, Scientist
Employer Northwell Health
Known forMedical Research
Website http://www.feinsteinneuroscience.org

David Eidelberg is an American neuroscientist who is a professor of Neurology and Molecular Medicine at the Zucker School of Medicine. [1] He is a neuroscientist best known for applying functional imaging of the brain to study neurological diseases.

Contents

Education and career

Eidelberg earned his BA at Columbia University in 1977, and his MD from Harvard Medical School (HMS) in 1981. [2] After completing residency training in neurology at the Harvard-Longwood Area Training Program, he pursued postdoctoral training as a Moseley Traveling Fellow at the National Hospital, Queen Square, in London, and at Memorial Sloan-Kettering Cancer Center in New York.

In 1988, Eidelberg joined North Shore University Hospital in Manhasset, New York, where he established the Functional Brain Imaging Laboratory and the Movement Disorders Center. He is Susan & Leonard Feinstein Professor of Neurology and Neuroscience at The Feinstein Institute for Medical Research, and Professor of Neurology and Molecular Medicine at the Zucker School of Medicine. He is the Director of the Feinstein Center for Neurosciences and an attending neurologist at North Shore University Hospital in Manhasset.

Research

Eidelberg has studied functional imaging methods to characterize large-scale network abnormalities in brain diseases like Parkinson's disease and dystonia. [3]

Awards and boards

Related Research Articles

<span class="mw-page-title-main">Dystonia</span> Neurological movement disorder

Dystonia is a neurological hyperkinetic movement disorder in which sustained or repetitive muscle contractions occur involuntarily, resulting in twisting and repetitive movements or abnormal fixed postures. The movements may resemble a tremor. Dystonia is often intensified or exacerbated by physical activity, and symptoms may progress into adjacent muscles.

<span class="mw-page-title-main">North Shore University Hospital</span> Hospital in New York, United States

North Shore University Hospital is a part of Northwell Health, New York State's largest healthcare provider and private employer. It is one of two primary teaching hospitals for the Zucker School of Medicine, offering residency programs, postgraduate training programs and clinical fellowships. It is located in Manhasset, New York, in Nassau County, on Long Island.

<span class="mw-page-title-main">McKnight Brain Institute</span> Neuroscience research center at the University of Florida

The Evelyn F. and William L. McKnight Brain Institute (MBI) at the University of Florida (UF) is a comprehensive and diverse neuroscience research center that houses the UF College of Medicine’s four “neuro” departments: neuroscience, neurology, neurosurgery and psychiatry.

Peter Franz Riederer is a German neuroscientist with several thousands of citations and around 950 scientific writings. He has published more than 620 scientific papers in peer-reviewed scientific journals that are indexed in Medline. He has been author and co-author of more than 20 books relevant to the fields of neuroscience, psychiatry and neurology.

<span class="mw-page-title-main">Kevin J. Tracey</span>

Kevin J. Tracey, a neurosurgeon and inventor, is the president and CEO of the Feinstein Institute for Medical Research, professor of neurosurgery and molecular medicine at the Zucker School of Medicine, and president of the Elmezzi Graduate School of Molecular Medicine in Manhasset, New York. The Public Library of Science Magazine, PLOS Biology, recognized Tracey in 2019 as one of the most cited researchers in the world.

John Quinn Trojanowski was an American academic research neuroscientist specializing in neurodegeneration. He and his partner, Virginia Man-Yee Lee, MBA, Ph.D., are noted for identifying the roles of three proteins in neurodegenerative diseases: tau in Alzheimer's disease, alpha-synuclein in Parkinson's disease, and TDP-43 in Amyotrophic Lateral Sclerosis (ALS) and frontotemporal degeneration.

<span class="mw-page-title-main">Ann Graybiel</span> American neuroscientist

Ann Martin Graybiel is an Institute Professor and a faculty member in the Department of Brain and Cognitive Sciences at the Massachusetts Institute of Technology. She is also an investigator at the McGovern Institute for Brain Research. She is an expert on the basal ganglia and the neurophysiology of habit formation, implicit learning, and her work is relevant to Parkinson's disease, Huntington's disease, obsessive–compulsive disorder, substance abuse and other disorders that affect the basal ganglia.

<span class="mw-page-title-main">Albert Gjedde</span>

Albert Gjedde: is a Danish-Canadian neuroscientist. He is Professor of Neurobiology and Pharmacology at the Faculty of Health Sciences and Center of Neuroscience at the University of Copenhagen. He is currently also Adjunct Professor of Neurology and Neurosurgery in the Department of Neurology, Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada, Adjunct Professor of Radiology and Radiological Science in the Division of Nuclear Medicine, Department of Radiology and Radiological Science, Johns Hopkins University, Baltimore, Maryland, US, Adjunct Professor of Translational Neuropsychiatry Research, University of Southern Denmark, Odense, Denmark, and adjunct professor of psychiatry at Tabriz University of Medical Sciences, Tabriz, East Azerbadjan, Iran.

Samuel E. Gandy, is a neurologist, cell biologist, Alzheimer's disease (AD) researcher and expert in the metabolism of the sticky substance called amyloid that clogs the brain in patients with Alzheimer's. His team discovered the first drugs that could lower the formation of amyloid.

<span class="mw-page-title-main">Anne B. Young</span> American neuroscientist

Anne Buckingham Young is an American physician and neuroscientist who has made major contributions to the study of neurodegenerative diseases, with a focus on movement disorders like Huntington's disease and Parkinson's disease. Young completed her undergraduate studies at Vassar College and earned a dual MD/PhD from Johns Hopkins Medical School. She has held faculty positions at University of Michigan and Harvard University. She became the first female chief of service at Massachusetts General Hospital when she was appointed Chief of Neurology in 1991. She retired from this role and from clinical service in 2012. She is a member of many academic societies and has won numerous awards. Young is also the only person to have been president of both the international Society for Neuroscience and the American Neurological Association.

<span class="mw-page-title-main">Joseph Jankovic</span> American neurologist

Joseph Jankovic is an American neurologist and professor at Baylor College of Medicine in Houston, Texas. He is the Distinguished Chair in Movement Disorders and founder and director of the Parkinson's Disease Center and Movement Disorders Clinic.

The White House BRAIN Initiative is a collaborative, public-private research initiative announced by the Obama administration on April 2, 2013, with the goal of supporting the development and application of innovative technologies that can create a dynamic understanding of brain function.

<span class="mw-page-title-main">Suh Yoo-hun</span> South Korean neuroscientist (born 1948)

Suh Yoo-hun is a South Korean neuroscientist. His researches focus on neurodegeneration, especially on the discovery of genes and therapies for Alzheimer's disease and Parkinson's disease.

<span class="mw-page-title-main">Alim Louis Benabid</span>

Alim Louis Benabid is a French-Algerian emeritus professor, neurosurgeon and member of the French Academy of Sciences, who has had a global impact in the development of deep brain stimulation (DBS) for Parkinson's disease and other movement disorders. He became emeritus professor of biophysics at the Joseph Fourier University in Grenoble in September 2007, and chairman of the board of the Edmond J. Safra Biomedical Research Center in 2009 at Clinatec, a multidisciplinary institute he co-founded in Grenoble that applies nanotechnologies to neurosciences.

<span class="mw-page-title-main">Yves Agid</span> French physician

Yves Agid is a neurologist, neuropsychiatrist, cell biologist, neurochemist, academician, university professor, hospital doctor, researcher in biology and scientist specializing in neurosciences.

<span class="mw-page-title-main">Rajiv Ratan</span> American physician

Rajiv Ratan is an Indian American academic, professor, administrator and scientist based in New York. He is the Burke Professor of Neurology and Neuroscience at Weill Cornell Medicine. Since 2003, he has served as the executive director of Burke Neurological Institute and as a member of the Council of Affiliated Deans of Weill Cornell Medicine.

<span class="mw-page-title-main">Bryce Vissel</span> Australian neuroscientist

Bryce Vissel is an Australian neuroscientist who is a professor of neuroscience at the University of New South Wales. He is the Director of the Centre for Neuroscience and Regenerative Medicine (CNRM) at St Vincent's Hospital Sydney. He is a specialist in neurodegenerative diseases, such as Alzheimer's, Parkinson's, and the neural basis of learning, memory and movement.

Ted M. Dawson is an American neurologist and neuroscientist. He is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases and Director of the Institute for Cell Engineering at Johns Hopkins University School of Medicine. He has joint appointments in the Department of Neurology, Neuroscience and Department of Pharmacology and Molecular Sciences.

Patrik Brundin is a neuroscientist known for his research on Parkinson's disease (PD) and Huntington's disease. He is currently a Distinguished Scientist and serving as Therapeutic Area Leader for Movement Disorders at F. Hoffmann-La Roche, Pharmaceutical Research and Early Development (pRED).

Jerrold Lee Vitek is an American neurologist. He is the Head of the Neurology Department, Director of the Neuromodulation Research Program, and Center Director of the University of Minnesota Udall Center of Excellence for Parkinson's Research. Vitek's clinical interests include movement disorders and evaluation for deep brain stimulation (DBS) and his current research activities focus on Parkinson's disease, dystonia, tremor and deep brain stimulation.

References

  1. "David Eidelberg M.D.'s Executive Work History". Equilar. Retrieved 9 December 2022.
  2. "Centers of Excellence". The Feinstein Institute for Medical Research. Retrieved 5 February 2014.
  3. "David Eidelberg PubMed Publications". PubMed.gov. National Library of Medicine. Retrieved 9 December 2022.
  4. "AAP Members" . Retrieved 5 November 2022.
  5. "michaeljfox.com". 12 November 2018. Retrieved 5 November 2022.
  6. "Scientific and Special Advisors". Michael J. Fox Foundation. Retrieved 5 February 2014.
  7. "About The Journal of Neuroscience". The Journal of Neuroscience. Archived from the original on 27 December 2013. Retrieved 5 February 2014.
  8. "Current Opinion in Neurology" . Retrieved 5 November 2022.
  9. "Scientific Advisory Board". Bachmann-Strauss Dystonia and Parkinson Foundation. Archived from the original on 3 April 2013. Retrieved 5 February 2014.
  10. "Striking at the Causes of Parkinson's" (PDF). The Thomas Hartman Foundation for Parkinson's Research, Inc. Archived from the original (PDF) on 21 March 2012. Retrieved 5 February 2014.
  11. "Past Award Winners". American Academy of Neurology. Archived from the original on 17 March 2012. Retrieved 5 February 2014.
  12. "The American Parkinson's Disease Association's Winter 2006 Newsletter" (PDF). American Parkinson's Disease Association. Retrieved 23 November 2022.
  13. "Editorial Board". Journal of Nuclear Medicine. Archived from the original on 28 May 2019. Retrieved 5 February 2014.
  14. "Editorial Board". Current Opinion in Neurology. Retrieved 5 February 2014.
  15. Fainardi, E.; Tamborino, C.; Bernardoni, A.; Busto, G.; Morotti, A. (2019). "Editorial Board". Annals of Neurology. 85: 943–947. doi: 10.1002/(ISSN)1531-8249 . hdl:2158/1164172 . Retrieved 5 February 2014.